Symbol="RNA"
AssetType="Common Stock"
Name="Avidity BiosciencesÂ Inc"
Description="Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California."
CIK="1599901"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="10975 N. TORREY PINES RD.,, #150, LA JOLLA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="631707000"
EBITDA="-200584992"
PERatio="None"
PEGRatio="0"
BookValue="7.89"
DividendPerShare="0"
DividendYield="0"
EPS="-3.17"
RevenuePerShareTTM="0.167"
ProfitMargin="0"
OperatingMarginTTM="-20.91"
ReturnOnAssetsTTM="-0.244"
ReturnOnEquityTTM="-0.411"
RevenueTTM="9662000"
GrossProfitTTM="-141180000"
DilutedEPSTTM="-3.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.244"
AnalystTargetPrice="37"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="119.0"
PriceToBookRatio="1.576"
EVToRevenue="24.07"
EVToEBITDA="-1.227"
Beta="-0.0651"
num_52WeekHigh="25.74"
num_52WeekLow="8.86"
num_50DayMovingAverage="11.16"
num_200DayMovingAverage="16.02"
SharesOutstanding="70819000"
DividendDate="None"
ExDividendDate="None"
symbol="RNA"
open="9.16"
high="9.33"
low="8.86"
price="9.31"
volume="1536119.00"
latest_trading_day="2023-07-26"
previous_close="9.16"
change="0.15"
change_percent="1.6376%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="81"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="19"
Volume_recent_avg="1247218"
Change_recent_avg="-0.1"
Delta_recent_avg="0.8"
Variance_recent_avg="0.4"
Change_ratio_recent_avg="-0.83"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="19"
Aroon_momentum_negative="81"
image_negative_thumbnail_id_1="1144"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0177.jpeg"
image_negative_thumbnail_id_2="94"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_neutral_thumbnail_id_1="547"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="705"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0003.jpeg"
image_positive_thumbnail_id_2="608"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0100.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
